Valeant Pharmaceuticals reported $562M in Operating Profit for its third fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Operating Profit Change
Amgen AMGN:US $ 2378M 1550M
Ani Pharmaceuticals ANIP:US $ -3562000 11.99M
Aphria Inc APH:CN C$ -68313000 25.11M
Aurora Cannabis Inc ACB:CN -40797000 112.66M
Biogen BIIB:US $ 794M 308.3M
Bristol Myers Squibb BMY:US $ 1996M 281M
Canopy Growth Corp WEED:CN C$ -215359000 25.31M
Catalent CTLT:US $ 134M 116.5M
Corcept Therapeutics CORT:US $ 36.23M 4.29M
Danaher DHR:US $ 1309M 696M
Drreddys Laboratories RDY:US $ 12115M 5508M
Eli Lilly And LLY:US $ 1476M 72.6M
Endo International Ordinary Shares ENDP:US $ 89.16M 53.95M
Gilead Sciences GILD:US $ 3842M 1596M
Gw Pharmaceuticals GWPH:US $ -21.03M 1.78M
Horizon Pharma HZNP:US $ 331.54M 193.03M
JAZZ PHA JAZZ:US $ 28.37M 97.96M
Lannett LCI:US $ -8.15M 25.68M
Nektar Therapeutics NKTR:US $ -113.6M 3.39M
Pacira Pharmaceuticals PCRX:US $ 31.43M 3.41M
Perrigo Ordinary Shares PRGO:US $ 438.3M 564.2M
Phibro Animal Health PAHC:US $ 14.61M 4.55M
Prestige Brands PBH:US $ 76.44M 14.91M
Revance Therapeutics RVNC:US $ -72723000 2.39M
Supernus Pharmaceuticals SUPN:US $ 32.6M 1.51M
Valeant Pharmaceuticals VRX:CN $ 562M 877M
Vertex Pharmaceuticals VRTX:US $ 1054.51M 1092.47M
Zoetis ZTS:US $ 659M 23M